Robert Burns

Stock Analyst at HC Wainwright & Co.

(2.09)
# 2,977
Out of 5,030 analysts
459
Total ratings
38.82%
Success rate
-5.82%
Average return
Main Sectors:

Stocks Rated by Robert Burns

ADC Therapeutics
Oct 16, 2025
Maintains: Buy
Price Target: $8$7
Current: $4.08
Upside: +71.57%
Nurix Therapeutics
Oct 14, 2025
Maintains: Buy
Price Target: $34$33
Current: $9.95
Upside: +231.66%
Zymeworks
Oct 14, 2025
Upgrades: Buy
Price Target: $13$26
Current: $18.45
Upside: +40.92%
Karyopharm Therapeutics
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $6.00
Upside: +150.05%
Perspective Therapeutics
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $4.65
Upside: +115.05%
Prelude Therapeutics
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $1.29
Upside: +287.60%
Nuvation Bio
Sep 19, 2025
Reiterates: Buy
Price Target: $10
Current: $3.53
Upside: +183.29%
BridgeBio Oncology Therapeutics
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $11.38
Upside: +137.36%
Cullinan Therapeutics
Sep 12, 2025
Reiterates: Buy
Price Target: $24
Current: $8.07
Upside: +197.40%
Immix Biopharma
Sep 12, 2025
Maintains: Buy
Price Target: $7$8
Current: $2.71
Upside: +195.20%
Maintains: Buy
Price Target: $23$20
Current: $10.77
Upside: +85.70%
Reiterates: Neutral
Price Target: n/a
Current: $4.57
Upside: -
Reiterates: Buy
Price Target: $136
Current: $104.45
Upside: +30.21%
Reiterates: Buy
Price Target: $34
Current: $2.88
Upside: +1,080.56%
Maintains: Buy
Price Target: $16$14
Current: $6.41
Upside: +118.41%
Maintains: Buy
Price Target: $41$40
Current: $18.33
Upside: +118.22%
Maintains: Buy
Price Target: $22$19
Current: $12.97
Upside: +46.49%
Maintains: Buy
Price Target: $40$42
Current: $19.86
Upside: +111.48%
Maintains: Buy
Price Target: $53$46
Current: $38.90
Upside: +18.25%
Maintains: Buy
Price Target: $12$10
Current: $3.97
Upside: +152.21%
Maintains: Buy
Price Target: $22$21
Current: $16.34
Upside: +28.52%
Maintains: Buy
Price Target: $18$10
Current: $2.20
Upside: +354.55%
Assumes: Buy
Price Target: $4
Current: $0.99
Upside: +304.04%
Maintains: Buy
Price Target: $10$13
Current: $9.69
Upside: +34.23%
Maintains: Buy
Price Target: $40$48
Current: $21.75
Upside: +120.69%
Reiterates: Buy
Price Target: $12
Current: $2.38
Upside: +404.20%
Maintains: Buy
Price Target: $73$72
Current: $54.67
Upside: +31.70%
Maintains: Buy
Price Target: $9$3
Current: $2.63
Upside: +14.07%
Reiterates: Buy
Price Target: $13
Current: $9.02
Upside: +44.12%
Maintains: Neutral
Price Target: $4$2
Current: $1.71
Upside: +16.96%
Reiterates: Buy
Price Target: $5
Current: $1.44
Upside: +247.22%
Maintains: Buy
Price Target: $9$8
Current: $1.24
Upside: +545.16%
Maintains: Buy
Price Target: $10$5
Current: $1.83
Upside: +173.22%
Reiterates: Neutral
Price Target: n/a
Current: $15.42
Upside: -
Maintains: Buy
Price Target: $500$200
Current: $33.75
Upside: +492.59%
Maintains: Buy
Price Target: $1,320$240
Current: $1.59
Upside: +14,994.34%
Reiterates: Buy
Price Target: $150
Current: $0.70
Upside: +21,482.73%
Downgrades: Neutral
Price Target: $115$7
Current: $1.49
Upside: +369.80%
Maintains: Buy
Price Target: $12$11
Current: $3.20
Upside: +243.75%
Maintains: Buy
Price Target: $50,000$45,000
Current: $5.17
Upside: +870,306.19%
Assumes: Buy
Price Target: $25
Current: $3.85
Upside: +549.35%
Maintains: Buy
Price Target: $19$13
Current: $1.61
Upside: +707.45%